Ascendia

  MARKET NEWS

Petros Pharmaceuticals Enters AI Licensing Agreement With Leading Multi-Billion-Dollar Software Provider
FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger With M2i Global
PathAI Announces Exclusive Collaboration With Roche Tissue Diagnostics to Advance AI-enabled Interpretation for Companion Diagnostics
TILT Biotherapeutics Awarded Grant from US Department of Defense for Ovarian Cancer Immunotherapy Research
Silo Pharma’s Ketamine Implant Demonstrates Successful Drug Delivery
Study Demonstrates the Potential of HelixBind’s RaPID/BSI Assay to Accurately Identify Bloodstream Infections Associated With Sepsis in Patients Undergoing Antimicrobial Treatment

  FEATURED EDITORIAL

  COMPANY PROFILE

Pace Life Sciences provides a full suite of contract CMC development, CTM manufacturing, regulatory compliance, consulting, and facility support services to the pharmaceutical, biopharmaceutical, and gene therapy industries. Pace Life Sciences operates from a network of CDMO sites, GMP analytical testing laboratories, and manufacturing support service centers across the United States. Our experienced, highly trained industry experts, and our investment in state-of-the-art development and manufacturing facilities emphasizes our commitment to efficiently advancing client programs through the clinic to commercialization. We are dedicated to delivering the best and most reliable services with positive customer experiences across all channels of our business. Click here for more.

  EXCLUSIVE ONLINE CONTENT

Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published

Vaxxinity’s Cholesterol Vaccine Candidate Successfully Lowers LDL-C: Preclinical Data Published

Preclinical data published in the Journal of Lipid Research indicate VXX-401 is well-tolerated, with no safety signals observed, and robustly reduces LDL-C in cynomolgus monkeys…..

VantAI Enters 4-Million Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence

VantAI Enters $674-Million Collaboration With Bristol Myers Squibb to Accelerate Molecular Glue Drug Discovery Through Artificial Intelligence

Collaboration to leverage VantAI’s expertise in generative AI and geometric deep learning to identify molecular glues against targets of interest with an option to expand to additional programs….

Vetter Contributes to Commercial Launches of Eight Customer Products in 2023

Vetter Contributes to Commercial Launches of Eight Customer Products in 2023

New molecules candidates brought to Vetter in the clinic receive strategic counsel and experienced support to guide their path to market and beyond….

Aptar CSP Technologies Collaborates With ProAmpac to Launch New Active Material Science Packaging Solution

Aptar CSP Technologies Collaborates With ProAmpac to Launch New Active Material Science Packaging Solution

High-performance, moisture-adsorbing flexible packaging powered by Activ-Polymer™ technology delivers simple, fully integrated protection for moisture-sensitive products….

  WHITEPAPERS & WEBINARS

WEBINAR - Step Into the Future of Therapeutic Antibody Discovery

WEBINAR - Step Into the Future of Therapeutic Antibody Discovery

Join us to hear about our new biotherapeutic antibody discovery service — the Pioneer Platform, and how it can help you find your next lead candidate.

WEBINAR - Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing

WEBINAR - Impact of Process Re-design on Sustainability in Pharmaceutical Small Molecule Manufacturing

Join us for an upcoming webinar that delves into a crucial issue in the pharmaceutical industry. Recent research has revealed a surprising fact: the pharmaceutical sector has a larger carbon footprint than even the automotive industry, especially when we consider the entire supply chain’s impact on

  WHITEPAPERS & WEBINARS

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

WHITEPAPER - Revolutionizing Small Molecule API Production: Unveiling the Impact of Fermentation as a Sustainable Solution

While large molecules continue to advance in drug development pipelines, small molecule Active Pharmaceutical Ingredients (APIs) still retain their historical dominance among new drug applications (NDAs). However, the last few years have seen the lines blurring between traditional chemical synthesis …

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

WHITEPAPER - Copolymer Microstructures: Connecting Monomer Sequence Distribution With Biomedical End-Application Performance

By: Dr. Bahar Yeniad and Dr. Pieter van Delft

Experts in copolymer microstructures have an important role to play in selecting biomaterials that can deliver desired performance of (bio)medical products. But how does microstructure link to the rate of API …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

February 28 – Drug Delivery
March 6 – Parenteral Contract Manufacturing